Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2537 of 6351
-
Can a breathing mask after surgery save lungs? new trial investigates
Prevention CompletedPostoperative pulmonary complications are one of the most common complications after surgery. Noninvasive ventilation has been proposed post-operatively to prevent postoperative pulmonary complications. Prophylactic noninvasive ventilation performed systematically in a non-spec…
Sponsor: Institut Cancerologie de l'Ouest • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
1905 SBMA patients monitored for up to 8 years on leuprorelin
Disease control CompletedThe purpose of this survey is to evaluate the long-term safety and efficacy of leuprorelin acetate injection kit 11.25 mg in patients with spinal and bulbar muscular atrophy (SBMA) in the routine clinical setting.
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New integrated therapy approach aims to transform eating disorder care
Disease control CompletedThis is a naturalistic study implementing a routine assessment to monitor the evolution of the patients with eating disorders being treated in various centers of "ITA salud mental" in Spain.
Sponsor: University of Barcelona • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Trauma ICU survivors: new study tracks hidden brain decline
Knowledge-focused OngoingCognitive skills are essential to live independently, manage finances, maintain employment, and function in society. Loss of these cognitive skills puts a tremendous burden on society as seen with dementias, Alzheimer's disease, and traumatic brain injury. The INSIGHT-ICU Study (…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Mindfulness may lift postnatal depression without pills
Symptom relief CompletedPostnatal psychopathology have adverse impact on both mothers and infants. Few postnatal women with depressive symptoms receive treatment, and pharmacological intervention has not been well accepted due to the medication side-effects. Recently, mindfulness-based interventions wer…
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Mining everyday radiotherapy data to sharpen cancer treatment
Knowledge-focused Recruiting nowProspective cohort study of patients receiving standard-care radiotherapy is paramount to a better understanding of radiation effects and longterm outcomes. The primary objective is to determine the feasibility of establishing infrastructure to systematically collect clinical da…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Blood thinners during prostate surgery: safe or not?
Disease control Recruiting nowBenign prostatic hyperplasia (BPH) is a very common pathology of the aging man with an incidence that rises from 40% in men aged 50 to 60 years to 90% in men over 80 years. Studies such as the MTOPS (the Medical Therapy of Prostatic Symptoms) study show that more than half of the…
Sponsor: Clinique Pasteur • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can incentives and special clinics help more people with HIV stay healthy?
Disease control CompletedThis clinical trial will compare the effectiveness of integrated care centers vs. integrated care centers plus HIV patient treatment incentives for achieving HIV treatment targets among people who inject drugs and men who have sex with men in India. The investigators will also as…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New blood test could spot pancreatic cancer sooner
Knowledge-focused Recruiting nowThe purpose of this study is to develop a minimally invasive test to diagnose pancreatic cancer at early stages of disease and monitor response to treatment.
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
New drug aims to protect hearts after attack
Disease control CompletedThe purpose of this study is to evaluate the safety, efficacy, and pharmacokinetics (PK) of three dose levels of FDY-5301 compared to placebo in STEMI patients undergoing PCI.
Phase 2 • Sponsor: Faraday Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Simple urine test may spot kidney damage in kids after heart surgery before standard methods
Diagnosis OngoingAcute kidney injury (AKI) is common in children after cardiac surgery with a reported incidence of 20-40%. Pediatric AKI has been found to be associated with important short and long-term adverse outcomes. A major challenge to management of AKI after cardiac surgery and cardiopu…
Sponsor: Boston Children's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Promising drug combo for Hard-to-Treat breast cancer falls short in early trial
Disease control Stopped earlyThis research study is studying a drug called Neratinib with and without Fulvestrant as possible treatments for HER2-positive breast cancer . The interventions involved in this study are: * Neratinib and Fulvestrant * Neratinib alone
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can a bone drug help women with anorexia? small study hints at hope
Disease control CompletedThis protocol is a randomized, double-blind, placebo-controlled clinical trial which aims to investigate the effect of denosumab on BMD in women with anorexia nervosa. The investigators hypothesize that 12 months of denosumab administration will result in an increase in bone mine…
Phase 3 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New combo therapy shows promise for Tough-to-Treat stomach cancer
Disease control CompletedThis research study is studying a combination of interventions as a possible treatment for gastroesophageal (GE) junction cancer. The interventions involved in this study are: -FOLFIRINOX which is made up of 4 different drugs: * 5-Fluorouracil (5-FU) * Oxaliplatin * Irinotecan…
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Heart pacing experiment: three spots better than two?
Disease control Stopped earlyCardiac resynchronization therapy (CRT) is a recommended treatment for selected patients with symptomatic heart failure (HF). Although most treated patients show a benefit from CRT, a lack of response is observed for about 25-30% of them whatever the response criteria used either…
Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could a common heart drug save babies with a rare birth defect?
Disease control CompletedInfants with congenital diaphragmatic hernia (CDH) usually have pulmonary hypoplasia and persistent pulmonary hypertension of the newborn (PPHN) leading to hypoxemic respiratory failure (HRF). Pulmonary hypertension associated with CDH is frequently resistant to conventional pulm…
Phase 2 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Experimental MS drug tested in kids, but study halted early
Disease control Stopped earlyPrimary Objective: To evaluate the efficacy, safety, and tolerability of alemtuzumab intravenously (IV) in pediatric participants from 10 to less than (\<) 18 years of age with Relapsing Remitting Multiple Sclerosis (RRMS) who have disease activity on prior DMT. Secondary Objec…
Phase 3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Dissolving stent could unblock bile ducts without extra surgery
Disease control Recruiting nowSTUDY TYPE: Feasibility study STUDY DESIGN: Prospective, multicenter, single-arm, open-label PRIMARY OBJECTIVE The primary objective is to assess safety of the UNITY Balloon-expandable Biodegradable Biliary Stent System SECONDARY OBJECTIVES Clinical /Technical /Procedural success…
Sponsor: QualiMed Innovative Medizinprodukte GmbH • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Diabetes drug empagliflozin tested in over 200,000 patients in Real-World setting
Disease control CompletedEmpagliflozin, a sodium glucose co-transporter 2 (SGLT-2) inhibitor, was launched as a treatment for type 2 diabetes mellitus (T2DM) in the U.S. in August 2014. In contrast with several previous cardiovascular outcomes trials, which failed to demonstrate an association with a hig…
Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Ultrasound gadget may speed up bone healing in thousands
Disease control CompletedThis study is one of three separate studies of the Bioventus Observational Non-interventional EXOGEN Studies (BONES) program. Eligibility for each study is determined by fractured bone.
Sponsor: Bioventus LLC • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC